![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Schuitemaker G.E. van der Pol G.A. Aretz C.P.M. Dinant G.J.
Publisher: Springer Publishing Company
ISSN: 0031-6970
Source: European Journal of Clinical Pharmacology, Vol.56, Iss.12, 2001-03, pp. : 857-863
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Mirici A.
Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Soltész S. Mencke T. Schlaich N. Fuchs-Buder T.
Clinical Drug Investigation, Vol. 21, Iss. 6, 2001-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lund Rasmussen Charlotte Klee Olsen Marc Thit Johnsen Anna Aagaard Petersen Morten Lindholm Helena Andersen Line Villadsen Birgit Groenvold Mogens Pedersen Lise
Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lazzaroni M. Casini V. Porro G. Bianchi
Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. :